Association of SIRT1 with metabolic parameters and aging rate
- Department of the Study of the Ageing Processes and Prevention of Metabolic-Associated Diseases, L.T. Malaya Therapy National Institute of National Academy of Medical Science of Ukraine, address: 2 a, Lyubovi Maloy ave., Kharkiv, 61039, Ukraine
- Laboratory of Immuno-Biochemical and Molecular Genetic Research, L.T. Malaya Therapy National Institute of National Academy of Medical Science of Ukraine, address: 2 a, Lyubovi Maloy ave., Kharkiv, 61039, Ukraine
Abstract
Introduction: SIRT1 has attracted great interest due to its role as a regulator of longevity, and its therapeutic potential for the prevention and treatment of aging and age-related comorbidities. However, the mechanisms by which SIRT1 influences the course of aging remain unknown.
Methods: The study population included 88 apparently healthy subjects aged 31 ? 65 without established atherosclerotic cardiovascular disease or metabolic-associated diseases. Clinical, anthropometric, and biochemical parameters were determined in all patients. Molecular genetic studies included the determination of the C/G polymorphism of the SIRT1 gene (SIRT1, rs7069102), relative telomere length of blood leukocytes (RTL-b), and telomerase activity. Biological age was calculated using the DNAm PhenoAge epigenetic clock.
Results: The SIRT1 serum levels in carriers of different genotypes of the G/C polymorphism (rs7069102) and in patients of different age groups did not differ. SIRT1 plasma levels in the accelerated aging group were significantly higher in comparison with the healthy aging group: (4.16 ? 1.18) ng/ml vs (3.47 ? 0.76) ng/ml, respectively (p = 0.00066). Correlation analysis revealed a positive correlation of the SIRT1 serum level with uric acid (R = 0.25; p = 0.023), tissue necrosis factor (R = 0.26; p = 0.014), total hydroperoxides (R = 0.33; p = 0.003) and a negative correlation with low-density lipoprotein cholesterol (R = -0.22; p = 0.039), telomerase activity (R = -0.39; p = 0.001) and total antioxidant activity (R = -0.35; p = 0.001). Stepwise regression analysis revealed negative association of the SIRT1 serum level with biological age.
Conclusion: SIRT1 plasma levels in apparently healthy subjects were associated with age, body mass index (BMI), WC, factors of carbohydrate metabolism, and markers of the pro-antioxidant balance. A comparative analysis of SIRT1 plasma levels between accelerated and healthy aging groups showed a significant difference. However, our study did not confirm that SNPs (rs7069102) of the SIRT1 genotypes are associated with SIRT1 plasma level, aging rate, or any metabolic parameters.